Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice

Area of Science:

• Ophthalmology
• Neuroscience
• Endocrinology

Background:

• Diabetic retinopathy (DR) can cause vision loss, often before vascular lesions appear.
• Early DR is associated with decreased retinal dopamine (DA) levels, impacting retinal function.
• Electroretinograms (ERGs) show abnormalities in diabetic retinas, suggesting potential as early biomarkers.

Purpose of the Study:

• To investigate if oscillatory potentials (OPs) in ERGs can detect early inner retinal dysfunction caused by retinal DA deficiency in diabetes.
• To establish OPs as a potential biomarker for early diabetic vision loss.

Main Methods:

• Diabetic and control mice underwent dark-adapted ERG testing at 3, 4, and 5 weeks post-diabetes induction.
• Retinal DA levels were correlated with ERG responses, specifically OPs.
• L-3,4-dihydroxyphenylalanine (L-DOPA) was used to restore DA levels, and retina-specific tyrosine hydroxylase (Th) knockout (rTHKO) mice were used to assess DA's role.

Main Results:

• Diabetic mice exhibited significantly delayed OPs compared to controls, particularly with dim light stimuli.
• L-DOPA treatment improved OP implicit time in diabetic mice.
• Diabetic rTHKO mice showed further OP delays, which were also ameliorated by L-DOPA, indicating DA's crucial role.

Conclusions:

• Early inner retinal dysfunction in diabetes is linked to rod pathway deficits and dopamine deficiency.
• OP delays in ERGs can serve as an early indicator of functional deficits in diabetic retinopathy.
• OPs may help identify an optimal window for dopamine-based therapies to prevent vision loss.